NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures
Primary Purpose
Fracture
Status
Unknown status
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
NovaLign Intramedullary Fixation System
Sponsored by
About this trial
This is an interventional treatment trial for Fracture focused on measuring Fracture, Humerus, Intramedullary, Fixation
Eligibility Criteria
Inclusion Criteria:
- Humeral Fracture
- Surgical intervention can be performed within 14 days of injury (injury being Day 0 for this particular criteria)
- Fully functioning contralateral limb (e.g., hand, arm, shoulder)
- Age 18 years or older and skeletally mature
Exclusion Criteria:
- Intraarticular fractures or those involving shoulder or elbow of the index arm
- Pathologic fracture (e.g., tumor involvement, osteomalacia, etc.; osteoporosis is not an exclusion)
- Evidence of neurologic injury in the index arm, including compartment syndrome or radial nerve palsy
- Additional upper body injuries (e.g., upper extremity, abdominal, thoracic, neck or head injury) that may affect or inhibit the evaluation of the index or contralateral arm, shoulder, elbow, etc or would not allow the patient to follow or comply with appropriate post-operative regimens
- Any previous bodily injury or surgery that may interfere with function or evaluation of index or contralateral arm, shoulder, elbow, etc.
Sites / Locations
- Denver Health Medical CenterRecruiting
- University of Missouri - ColumbiaRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Intramedullary Fixation System
Arm Description
Humeral fractures to be treated with the Intramedullary Fixation System
Outcomes
Primary Outcome Measures
Radiographic union and safety
Secondary Outcome Measures
Function, pain, and quality of life assessments at regular intervals
Full Information
NCT ID
NCT00969839
First Posted
August 30, 2009
Last Updated
September 16, 2009
Sponsor
NovaLign Orthopaedics, Inc
1. Study Identification
Unique Protocol Identification Number
NCT00969839
Brief Title
NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures
Official Title
A Study to Evaluate the Safety and Effectiveness of the NovaLign Intramedullary Fixation System for the Treatment of Humeral Diaphysis Fractures
Study Type
Interventional
2. Study Status
Record Verification Date
September 2009
Overall Recruitment Status
Unknown status
Study Start Date
September 2009 (undefined)
Primary Completion Date
March 2011 (Anticipated)
Study Completion Date
March 2011 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
NovaLign Orthopaedics, Inc
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This post-market clinical study is being done to evaluate the use of the NovaLign™ Intramedullary Fixation System in the treatment of humeral fractures.
Detailed Description
This is an observational, prospective, nonrandomized open label, post-market clinical study, designed to evaluate the use a flexible intramedullary fixation device used in the treatment of fractures of the humerus. This is a multicentre trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Fracture
Keywords
Fracture, Humerus, Intramedullary, Fixation
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Intramedullary Fixation System
Arm Type
Experimental
Arm Description
Humeral fractures to be treated with the Intramedullary Fixation System
Intervention Type
Device
Intervention Name(s)
NovaLign Intramedullary Fixation System
Intervention Description
Intramedullary fixation of broken humerus
Primary Outcome Measure Information:
Title
Radiographic union and safety
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Function, pain, and quality of life assessments at regular intervals
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Humeral Fracture
Surgical intervention can be performed within 14 days of injury (injury being Day 0 for this particular criteria)
Fully functioning contralateral limb (e.g., hand, arm, shoulder)
Age 18 years or older and skeletally mature
Exclusion Criteria:
Intraarticular fractures or those involving shoulder or elbow of the index arm
Pathologic fracture (e.g., tumor involvement, osteomalacia, etc.; osteoporosis is not an exclusion)
Evidence of neurologic injury in the index arm, including compartment syndrome or radial nerve palsy
Additional upper body injuries (e.g., upper extremity, abdominal, thoracic, neck or head injury) that may affect or inhibit the evaluation of the index or contralateral arm, shoulder, elbow, etc or would not allow the patient to follow or comply with appropriate post-operative regimens
Any previous bodily injury or surgery that may interfere with function or evaluation of index or contralateral arm, shoulder, elbow, etc.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
B Crist, MD
Organizational Affiliation
University of Missouri-Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Denver Health Medical Center
City
Denver
State/Province
Colorado
ZIP/Postal Code
80204
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
S Morgan, MD
Phone
303-602-3796
First Name & Middle Initial & Last Name & Degree
A Baron
Phone
(303) 602-3796
First Name & Middle Initial & Last Name & Degree
S Morgan, MD
Facility Name
University of Missouri - Columbia
City
Columbia
State/Province
Missouri
ZIP/Postal Code
65212
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
B Crist, MD
Phone
573-884-0854
First Name & Middle Initial & Last Name & Degree
L Anderson, RN
Phone
(573) 884-0854
First Name & Middle Initial & Last Name & Degree
B Crist, MD
12. IPD Sharing Statement
Learn more about this trial
NovaLign Intramedullary Fixation System (IFS) for the Treatment of Humeral Fractures
We'll reach out to this number within 24 hrs